
NATURE . COM {
}
Title:
1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells | Cell Death & Disease
Description:
Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌆 Monumental Traffic: 20M - 50M visitors per month
Based on our best estimate, this website will receive around 42,555,829 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$536,300 per month
Our calculations suggest that Nature.com earns between $357,511 and $983,155 monthly online from display advertisements.
Keywords {🔍}
cells, irx, gefitinib, cancer, nanog, cell, expression, pcgr, fig, article, resistance, properties, google, scholar, china, lung, western, cas, stemlike, ohd, treatment, stem, blotting, protein, nsclc, tumor, signaling, combination, tgfβ, cytotoxicity, results, group, analysis, nature, egfrtki, increased, inhibited, stemness, experiments, transfected, usa, sirna, growth, celllike, treated, significantly, levels, assay, nanjing, viability,
Topics {✒️}
nature portfolio beta-catenin-mediated epithelial-mesenchymal transition vdr/plc-gamma1/tgf-beta1/pathway serum‐free opti‐mem media research groups privacy policy tgf-β/smad signaling-induced irx4 tgf-β1/smad3 signaling pathway tgf-β/smad signaling pathway28 nature small-molecule multi-kinase inhibitor20 advertising erk1/2-mzf1 signaling pathway reprints tgf-β1/smad3 signaling japan activating stat3/cxcl1 axis 2d3 signaling-induced decreases egfr-tyrosine kinase inhibitors small-cell lung cancer egfr-tki resistant cells irx4-mediated cancer stem potentiates cell death social media poor egfr-tki sensitivity inhibit egfr-tki resistance irx4-expressing cell lines nanog-mediated stem cell state key laboratory regulating egfr-tki resistance cd44+cd133+ pc-9/gr cells increase egfr-tki resistance high tgf-β1 levels irx-family genes participate egfr-mutant nsclc cells9 contract number hh20190622lhy-lv03 ventricular-specific progenitor cell multi-directional differentiation potential pnanog-luc reporter activity irx4+mouse embryonic cells original author tgf-β1 induced permissions sirna/plasmid‐lipid complexes lung cancer progression tyrosine kinase inhibitors 20 ng/ml tgf-β1 delayed development cell death dis pre-clinical models support
Questions {❓}
- How IRX4 controls gefitinib cytotoxicity?
- How to regulate IRX4-mediated cancer stem-like properties and gefitinib resistance?
Schema {🗺️}
WebPage:
mainEntity:
headline:1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
description:Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
datePublished:2020-08-20T00:00:00Z
dateModified:2020-08-20T00:00:00Z
pageStart:1
pageEnd:15
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1038/s41419-020-02908-w
keywords:
Cancer
Cancer therapy
Life Sciences
general
Biochemistry
Cell Biology
Immunology
Cell Culture
Antibodies
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig7_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig8_HTML.png
isPartOf:
name:Cell Death & Disease
issn:
2041-4889
volumeNumber:11
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Zhirong Jia
url:http://orcid.org/0000-0002-7381-5150
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Yameng Zhang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Aiwen Yan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Meisa Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Qiushuang Han
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Kaiwei Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Jie Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:the First Affiliated Hospital of Xinjiang Medical University
address:
name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
type:PostalAddress
type:Organization
type:Person
name:Chen Qiao
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Zhenzhen Pan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Chuansheng Chen
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Dong Hu
affiliation:
name:Anhui University of Science and Technology
address:
name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Xuansheng Ding
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
description:Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
datePublished:2020-08-20T00:00:00Z
dateModified:2020-08-20T00:00:00Z
pageStart:1
pageEnd:15
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1038/s41419-020-02908-w
keywords:
Cancer
Cancer therapy
Life Sciences
general
Biochemistry
Cell Biology
Immunology
Cell Culture
Antibodies
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig7_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig8_HTML.png
isPartOf:
name:Cell Death & Disease
issn:
2041-4889
volumeNumber:11
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Zhirong Jia
url:http://orcid.org/0000-0002-7381-5150
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Yameng Zhang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Aiwen Yan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Meisa Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Qiushuang Han
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Kaiwei Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Jie Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:the First Affiliated Hospital of Xinjiang Medical University
address:
name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
type:PostalAddress
type:Organization
type:Person
name:Chen Qiao
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Zhenzhen Pan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Chuansheng Chen
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Dong Hu
affiliation:
name:Anhui University of Science and Technology
address:
name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Xuansheng Ding
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Cell Death & Disease
issn:
2041-4889
volumeNumber:11
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:the First Affiliated Hospital of Xinjiang Medical University
address:
name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:Anhui University of Science and Technology
address:
name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Zhirong Jia
url:http://orcid.org/0000-0002-7381-5150
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Yameng Zhang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Aiwen Yan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Meisa Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Qiushuang Han
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Kaiwei Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Jie Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:the First Affiliated Hospital of Xinjiang Medical University
address:
name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
type:PostalAddress
type:Organization
name:Chen Qiao
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Zhenzhen Pan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Chuansheng Chen
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Dong Hu
affiliation:
name:Anhui University of Science and Technology
address:
name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
type:PostalAddress
type:Organization
email:[email protected]
name:Xuansheng Ding
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
External Links {🔗}(114)
- How much does https://orcid.org/0000-0002-7381-5150 bring in each month?
- Profit of https://doi.org/10.1016%2FS0140-6736%2817%2933326-3
- http://scholar.google.com/scholar_lookup?&title=Global%20surveillance%20of%20trends%20in%20cancer%20survival%202000-14%20%28CONCORD-3%29%3A%20analysis%20of%20individual%20records%20for%2037%20513%20025%20patients%20diagnosed%20with%20one%20of%2018%20cancers%20from%20322%20population-based%20registries%20in%2071%20countries&journal=Lancet&doi=10.1016%2FS0140-6736%2817%2933326-3&volume=391&pages=1023-1075&publication_year=2018&author=Allemani%2CC's revenue stream
- What is the monthly revenue of https://doi.org/10.1200%2FJCO.2012.45.3753?
- What's http://scholar.google.com/scholar_lookup?&title=Genotyping%20and%20genomic%20profiling%20of%20non-small-cell%20lung%20cancer%3A%20implications%20for%20current%20and%20future%20therapies&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.2012.45.3753&volume=31&pages=1039-1049&publication_year=2013&author=Li%2CT&author=Kung%2CHJ&author=Mack%2CPC&author=Gandara%2CDR's gross income?
- https://doi.org/10.6004%2Fjnccn.2018.0062 income
- How much profit does http://scholar.google.com/scholar_lookup?&title=NCCN%20guidelines%20insights%3A%20non-small%20cell%20lung%20cancer%2C%20Version%205.2018&journal=J.%20Natl%20Compr.%20Canc%20Netw.&doi=10.6004%2Fjnccn.2018.0062&volume=16&pages=807-821&publication_year=2018&author=Ettinger%2CDS generate?
- What is the earnings of https://doi.org/10.1038%2Fcddis.2014.447?
- How much does http://scholar.google.com/scholar_lookup?&title=A%20novel%20antagonist%20to%20the%20inhibitors%20of%20apoptosis%20%28IAPs%29%20potentiates%20cell%20death%20in%20EGFR-overexpressing%20non-small-cell%20lung%20cancer%20cells&journal=Cell%20Death%20Dis.&doi=10.1038%2Fcddis.2014.447&volume=5&publication_year=2014&author=Lee%2CSH pull in?
- What is the monthly revenue of https://doi.org/10.2174%2F1574887114666181205155211?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Advanced%20non-small%20cell%20lung%20cancer%20with%20activating%20epidermal%20growth%20factor%20receptor%20mutation%3A%20first%20line%20treatment%20and%20beyond&journal=Rev.%20Recent%20Clin.%20Trials&doi=10.2174%2F1574887114666181205155211&volume=14&pages=120-128&publication_year=2019&author=Rocco%2CD&author=Battiloro%2CC&author=Gravara%2CLD&author=Gridelli%2CC produce monthly?
- How much income is https://link.springer.com/doi/10.1007/s40264-018-0772-x earning monthly?
- See how much http://scholar.google.com/scholar_lookup?&title=Safety%20and%20tolerability%20of%20epidermal%20growth%20factor%20receptor%20%28EGFR%29%20tyrosine%20kinase%20inhibitors%20in%20oncology&journal=Drug%20Saf.&doi=10.1007%2Fs40264-018-0772-x&volume=42&pages=181-198&publication_year=2019&author=Shah%2CRR&author=Shah%2CDR makes per month
- Get to know what's the income of https://doi.org/10.1016%2Fj.resinv.2018.09.001
- Earnings of http://scholar.google.com/scholar_lookup?&title=Resistance%20to%20molecularly%20targeted%20therapy%20in%20non-small-cell%20lung%20cancer&journal=Respir.%20Investig.&doi=10.1016%2Fj.resinv.2018.09.001&volume=57&pages=20-26&publication_year=2019&author=Asao%2CT&author=Takahashi%2CF&author=Takahashi%2CK
- How much does https://doi.org/10.1111%2Fcas.12749 pull in?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Acquisition%20of%20cancer%20stem%20cell-like%20properties%20in%20non-small%20cell%20lung%20cancer%20with%20acquired%20resistance%20to%20afatinib&journal=Cancer%20Sci.&doi=10.1111%2Fcas.12749&volume=106&pages=1377-1384&publication_year=2015&author=Hashida%2CS make?
- What's the income of https://doi.org/10.1038%2Fs41467-018-05626-2?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Notch3-dependent%20beta-catenin%20signaling%20mediates%20EGFR%20TKI%20drug%20persistence%20in%20EGFR%20mutant%20NSCLC&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-018-05626-2&volume=9&publication_year=2018&author=Arasada%2CRR?
- How much does https://doi.org/10.1111%2Fcrj.12976 generate monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=CD146-mediated%20acquisition%20of%20stemness%20phenotype%20enhances%20tumour%20invasion%20and%20metastasis%20after%20EGFR-TKI%20resistance%20in%20lung%20cancer&journal=Clin.%20Respir.%20J.&doi=10.1111%2Fcrj.12976&volume=13&pages=23-33&publication_year=2019&author=Zhang%2CF have?
- What's the total monthly financial gain of https://doi.org/10.1158%2F0008-5472.CAN-12-4136?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20EGFR%20inhibitors%20is%20associated%20with%20a%20manifestation%20of%20stem%20cell-like%20properties%20in%20cancer%20cells&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-12-4136&volume=73&pages=3051-3061&publication_year=2013&author=Shien%2CK have monthly?
- How much income does https://doi.org/10.1016%2Fj.canlet.2018.07.020 have?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Genome-wide%20identification%20of%20transcription%20factors%20that%20are%20critical%20to%20non-small%20cell%20lung%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2018.07.020&volume=434&pages=132-143&publication_year=2018&author=Zhang%2CDL?
- What's the income of https://link.springer.com/doi/10.1007/s00429-016-1326-6?
- How much does http://scholar.google.com/scholar_lookup?&title=Expression%20patterns%20of%20Irx%20genes%20in%20the%20developing%20chick%20inner%20ear&journal=Brain%20Struct.%20Funct.&doi=10.1007%2Fs00429-016-1326-6&volume=222&pages=2071-2092&publication_year=2017&author=Cardena-Nunez%2CS net monthly?
- How much revenue does https://doi.org/10.1038%2Fncomms1301 generate?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=An%20evolutionarily%20conserved%20three-dimensional%20structure%20in%20the%20vertebrate%20Irx%20clusters%20facilitates%20enhancer%20sharing%20and%20coregulation&journal=Nat.%20Commun.&doi=10.1038%2Fncomms1301&volume=2&publication_year=2011&author=Tena%2CJJ?
- How much does https://doi.org/10.1002%2Fstem.2486 net monthly?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Irx4%20marks%20a%20multipotent%2C%20ventricular-specific%20progenitor%20cell&journal=Stem%20Cells&doi=10.1002%2Fstem.2486&volume=34&pages=2875-2888&publication_year=2016&author=Nelson%2CDO
- Check the income stats for https://doi.org/10.1016%2Fj.mcn.2008.11.003
- How much money does http://scholar.google.com/scholar_lookup?&title=Formation%20of%20posterior%20cranial%20placode%20derivatives%20requires%20the%20Iroquois%20transcription%20factor%20irx4a&journal=Mol.%20Cell%20Neurosci.&doi=10.1016%2Fj.mcn.2008.11.003&volume=40&pages=328-337&publication_year=2009&author=Feijoo%2CCG&author=Saldias%2CMP&author=Paz%2CJF&author=Gomez-Skarmeta%2CJL&author=Allende%2CML make?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22213310 earns monthly
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Vitamin%20D%3A%20potential%20in%20the%20prevention%20and%20treatment%20of%20lung%20cancer&journal=Anticancer%20Res.&volume=32&pages=211-221&publication_year=2012&author=Norton%2CR&author=O%E2%80%99Connell%2CMA?
- Financial intake of https://doi.org/10.1016%2Fj.jsbmb.2012.09.022
- How much profit is http://scholar.google.com/scholar_lookup?&title=Differential%20response%20to%201alpha%2C25-dihydroxyvitamin%20D3%20%281alpha%2C25%28OH%292D3%29%20in%20non-small%20cell%20lung%20cancer%20cells%20with%20distinct%20oncogene%20mutations&journal=J.%20Steroid%20Biochem%20Mol.%20Biol.&doi=10.1016%2Fj.jsbmb.2012.09.022&volume=136&pages=264-270&publication_year=2013&author=Zhang%2CQ making per month?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31002352 have monthly?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=1alpha%2C25Dihydroxyvitamin%20D3%20restrains%20stem%20celllike%20properties%20of%20ovarian%20cancer%20cells%20by%20enhancing%20vitamin%20D%20receptor%20and%20suppressing%20CD44&journal=Oncol.%20Rep.&volume=41&pages=3393-3403&publication_year=2019&author=Ji%2CM&author=Liu%2CL&author=Hou%2CY&author=Li%2CB have monthly?
- What's the financial intake of https://doi.org/10.1016%2Fj.stem.2018.11.017?
- How much does http://scholar.google.com/scholar_lookup?&title=Targeting%20cancer%20stemness%20in%20the%20clinic%3A%20from%20hype%20to%20hope&journal=Cell%20Stem%20Cell&doi=10.1016%2Fj.stem.2018.11.017&volume=24&pages=25-40&publication_year=2019&author=Saygin%2CC&author=Matei%2CD&author=Majeti%2CR&author=Reizes%2CO&author=Lathia%2CJD net monthly?
- Earnings of https://doi.org/10.1016%2Fj.canlet.2019.03.027
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Protective%20autophagy%20decreases%20osimertinib%20cytotoxicity%20through%20regulation%20of%20stem%20cell-like%20properties%20in%20lung%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2019.03.027&volume=452&pages=191-202&publication_year=2019&author=Li%2CL
- How much income is https://doi.org/10.1038%2Fs41388-018-0589-1 earning monthly?
- What's http://scholar.google.com/scholar_lookup?&title=Cancer%20stem-like%20properties%20and%20gefitinib%20resistance%20are%20dependent%20on%20purine%20synthetic%20metabolism%20mediated%20by%20the%20mitochondrial%20enzyme%20MTHFD2&journal=Oncogene&doi=10.1038%2Fs41388-018-0589-1&volume=38&pages=2464-2481&publication_year=2019&author=Nishimura%2CT's gross income?
- Income figures for https://doi.org/10.18632%2Foncotarget.3389
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=IL-8%20confers%20resistance%20to%20EGFR%20inhibitors%20by%20inducing%20stem%20cell%20properties%20in%20lung%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.3389&volume=6&pages=10415-10431&publication_year=2015&author=Liu%2CYN each month?
- Check the income stats for https://doi.org/10.1002%2Fstem.29
- How much profit does http://scholar.google.com/scholar_lookup?&title=Functional%20evidence%20that%20the%20self-renewal%20gene%20NANOG%20regulates%20human%20tumor%20development&journal=Stem%20Cells&doi=10.1002%2Fstem.29&volume=27&pages=993-1005&publication_year=2009&author=Jeter%2CCR generate?
- How much does https://doi.org/10.1158%2F0008-5472.CAN-10-3320 pull in monthly?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=HIF%20induces%20human%20embryonic%20stem%20cell%20markers%20in%20cancer%20cells&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-10-3320&volume=71&pages=4640-4652&publication_year=2011&author=Mathieu%2CJ
- https://doi.org/10.1016%2Fj.suronc.2013.08.001's revenue stream
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Nanog%2C%20a%20novel%20prognostic%20marker%20for%20lung%20cancer&journal=Surg.%20Oncol.&doi=10.1016%2Fj.suronc.2013.08.001&volume=22&pages=224-229&publication_year=2013&author=Du%2CY
- What's the financial intake of https://doi.org/10.1158%2F1078-0432.CCR-14-2437?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Activation%20of%20vitamin%20D%20receptor%20signaling%20downregulates%20the%20expression%20of%20nuclear%20FOXM1%20protein%20and%20suppresses%20pancreatic%20cancer%20cell%20stemness&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-14-2437&volume=21&pages=844-853&publication_year=2015&author=Li%2CZ
- How much revenue does https://doi.org/10.1111%2Fcas.14237 produce monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Calcitriol%20inhibits%20migration%20and%20invasion%20of%20renal%20cell%20carcinoma%20cells%20by%20suppressing%20Smad2%2F3-%2C%20STAT3-%20and%20beta-catenin-mediated%20epithelial-mesenchymal%20transition&journal=Cancer%20Sci.&doi=10.1111%2Fcas.14237&volume=111&pages=59-71&publication_year=2020&author=Xu%2CS?
- How much profit does https://doi.org/10.1016%2Fj.molimm.2017.09.006 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=1%2C25%28OH%292D3%20induces%20regulatory%20T%20cell%20differentiation%20by%20influencing%20the%20VDR%2FPLC-gamma1%2FTGF-beta1%2Fpathway&journal=Mol.%20Immunol.&doi=10.1016%2Fj.molimm.2017.09.006&volume=91&pages=156-164&publication_year=2017&author=Zhou%2CQ rake in every month?
- How much does https://doi.org/10.1038%2Fs41556-018-0062-y rake in every month?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=PSPC1%20mediates%20TGF-beta1%20autocrine%20signalling%20and%20Smad2%2F3%20target%20switching%20to%20promote%20EMT%2C%20stemness%20and%20metastasis&journal=Nat.%20Cell%20Biol.&doi=10.1038%2Fs41556-018-0062-y&volume=20&pages=479-491&publication_year=2018&author=Yeh%2CHW?
- Learn about the earnings of https://doi.org/10.1111%2Ffebs.14162
- http://scholar.google.com/scholar_lookup?&title=TGF-beta1-induced%20CK17%20enhances%20cancer%20stem%20cell-like%20properties%20rather%20than%20EMT%20in%20promoting%20cervical%20cancer%20metastasis%20via%20the%20ERK1%2F2-MZF1%20signaling%20pathway&journal=FEBS%20J.&doi=10.1111%2Ffebs.14162&volume=284&pages=3000-3017&publication_year=2017&author=Wu%2CL's total income per month
- Learn about the earnings of https://doi.org/10.1016%2Fj.biopha.2015.10.018
- How much does http://scholar.google.com/scholar_lookup?&title=TGF-beta1%20induces%20erlotinib%20resistance%20in%20non-small%20cell%20lung%20cancer%20by%20down-regulating%20PTEN&journal=Biomed.%20Pharmacother.&doi=10.1016%2Fj.biopha.2015.10.018&volume=77&pages=1-6&publication_year=2016&author=Shen%2CH generate monthly?
- Get to know what's the income of https://doi.org/10.1158%2F1535-7163.MCT-13-0448
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=MiR-134%2F487b%2F655%20cluster%20regulates%20TGF-beta-induced%20epithelial-mesenchymal%20transition%20and%20drug%20resistance%20to%20gefitinib%20by%20targeting%20MAGI2%20in%20lung%20adenocarcinoma%20cells&journal=Mol.%20Cancer%20Ther.&doi=10.1158%2F1535-7163.MCT-13-0448&volume=13&pages=444-453&publication_year=2014&author=Kitamura%2CK
- What's the profit of https://doi.org/10.1038%2Fncomms1880?
- How much income does http://scholar.google.com/scholar_lookup?&title=Loss-of-function%20of%20inositol%20polyphosphate-4-phosphatase%20reversibly%20increases%20the%20severity%20of%20allergic%20airway%20inflammation&journal=Nat.%20Commun.&doi=10.1038%2Fncomms1880&volume=3&publication_year=2012&author=Aich%2CJ&author=Mabalirajan%2CU&author=Ahmad%2CT&author=Agrawal%2CA&author=Ghosh%2CB have?
- How much revenue does https://doi.org/10.1073%2Fpnas.1009472107 produce monthly?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=TGF-beta%20IL-6%20axis%20mediates%20selective%20and%20adaptive%20mechanisms%20of%20resistance%20to%20molecular%20targeted%20therapy%20in%20lung%20cancer&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.1009472107&volume=107&pages=15535-15540&publication_year=2010&author=Yao%2CZ
- What's the monthly income of https://link.springer.com/doi/10.1186/s13046-019-1120-4?
- http://scholar.google.com/scholar_lookup?&title=Co-administration%20of%2020%28S%29-protopanaxatriol%20%28g-PPT%29%20and%20EGFR-TKI%20overcomes%20EGFR-TKI%20resistance%20by%20decreasing%20SCD1%20induced%20lipid%20accumulation%20in%20non-small%20cell%20lung%20cancer&journal=J.%20Exp.%20Clin.%20Cancer%20Res&doi=10.1186%2Fs13046-019-1120-4&volume=38&publication_year=2019&author=Huang%2CQ's financial summary
- How much does https://link.springer.com/doi/10.1186/s13046-018-0894-0 gross monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=FOXC1%20induces%20cancer%20stem%20cell-like%20properties%20through%20upregulation%20of%20beta-catenin%20in%20NSCLC&journal=J.%20Exp.%20Clin.%20Cancer%20Res.&doi=10.1186%2Fs13046-018-0894-0&volume=37&publication_year=2018&author=Cao%2CS earns monthly
- Learn how profitable https://doi.org/10.1158%2F1078-0432.CCR-13-2613 is on a monthly basis
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Metformin%20sensitizes%20EGFR-TKI-resistant%20human%20lung%20cancer%20cells%20in%20vitro%20and%20in%20vivo%20through%20inhibition%20of%20IL-6%20signaling%20and%20EMT%20reversal&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-13-2613&volume=20&pages=2714-2726&publication_year=2014&author=Li%2CL?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1038/s41419-020-02908-w?format=refman&flavour=references bring in?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhirong%20Jia make?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhirong%20Jia%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yameng%20Zhang make?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yameng%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Aiwen%20Yan rake in every month?
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Aiwen%20Yan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Meisa%20Wang income
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Meisa%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Qiushuang%20Han
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Qiushuang%20Han%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kaiwei%20Wang's earnings
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kaiwei%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jie%20Wang have?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jie%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chen%20Qiao each month?
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chen%20Qiao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhenzhen%20Pan
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhenzhen%20Pan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chuansheng%20Chen
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chuansheng%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dong%20Hu makes per month
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dong%20Hu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xuansheng%20Ding making per month?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xuansheng%20Ding%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- How much does http://creativecommons.org/licenses/by/4.0/ pull in monthly?
- How much money does https://s100.copyright.com/AppDispatchServlet?title=1%2C25-dihydroxyvitamin%20D3%20signaling-induced%20decreases%20in%20IRX4%20inhibits%20NANOG-mediated%20cancer%20stem-like%20properties%20and%20gefitinib%20resistance%20in%20NSCLC%20cells&author=Zhirong%20Jia%20et%20al&contentID=10.1038%2Fs41419-020-02908-w©right=The%20Author%28s%29&publication=2041-4889&publicationDate=2020-08-20&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY make?
- Check the income stats for https://crossmark.crossref.org/dialog/?doi=10.1038/s41419-020-02908-w
- What's the financial intake of https://citation-needed.springer.com/v2/references/10.1038/s41419-020-02908-w?format=refman&flavour=citation?
- How much revenue does https://doi.org/10.1007/s10555-024-10171-0 generate?
- How much profit is https://doi.org/10.1186/s12943-023-01877-w making per month?
- Profit of https://doi.org/10.1007/s12032-023-02210-7
- How much profit is https://doi.org/10.1038/s41420-022-00918-5 making per month?
- See how much https://www.protocols.io/ makes per month
- What's https://www.natureindex.com/'s gross income?
- How much money does http://www.naturechina.com generate?
- How much does https://www.natureasia.com/ja-jp net monthly?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref